Transversus Abdominis Plane Block on Stress Response
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03035916 |
|
Recruitment Status :
Completed
First Posted : January 30, 2017
Results First Posted : December 15, 2017
Last Update Posted : January 23, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Gastrostomy | Other: Transversus abdominis plane block Other: Epidural anesthesia Other: control | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 91 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effect of Transversus Abdominis Plane Block Combined With General Anesthesia on Perioperative Stress Response in Patients Undergoing Radical Gastrectomy: A Double-blind Randomized Controlled Study. |
| Actual Study Start Date : | January 20, 2017 |
| Actual Primary Completion Date : | May 31, 2017 |
| Actual Study Completion Date : | July 15, 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Transversus abdominis plane block
The TAP group receives ultrasound-guided TAP block under bilateral costal margin with multiple injections of 40ml 0.375% ropivacaine after the induction of general anesthesia.
|
Other: Transversus abdominis plane block
Participants in this group receive ultrasound-guided TAP block under bilateral costal margin with multiple injections of 40ml 0.375% ropivacaine after the induction of general anesthesia, 30 minutes later the surgery will be started. |
|
Active Comparator: Epidural anesthesia
The Epidural group receives epidural block (T8-9) 2 mL of 1.6% lidocaine as a test dose and continous infusion of 0.375% ropivacaine(5 mL/h) during the surgery.
|
Other: Epidural anesthesia
Participants in the Epidural group receive a epidural block (T8-9) with 2 mL of 1.6% lidocaine as a test dose before induction. After a successful placement of epidural catheter, the block then is established with 5 mL of 0.375% ropivacaine and continous infusion of 0.375% ropivacaine(5 mL/h) during the surgery. |
|
Placebo Comparator: Control
The Control group receives standard IV-inhaled general anesthesia.
|
Other: control
The Control group receives standard IV-inhaled general anesthesia. |
- Physiological Parameters: Plasma Concentration of Norepinephrine (NE) [ Time Frame: up to 48h after surgery ]Venous blood samples will be collected at certain time points. The blood samples are collected in a pre-chilled tubes in ice and are centrifuged within 90min, and then separated plasma are stored at -80°C until analysis. The NE levels are measured by ELISA kits.
- Physiological Parameters: Plasma Concentration of Epinephrine (E) [ Time Frame: up to 48h after surgery ]Venous blood samples will be collected at certain time points. The blood samples are collected in a pre-chilled tubes in ice and are centrifuged within 90min, and then separated plasma are stored at -80°C until analysis. The E levels are measured by ELISA kits.
- Physiological Parameters: Plasma Concentration of Cortisol (Cor) [ Time Frame: up to 48h after surgery ]Venous blood samples will be collected at certain time points. The blood samples are collected in a pre-chilled tubes in ice and are centrifuged within 90min, and then separated plasma are stored at -80°C until analysis. The Cor levels are measured by ELISA kits.
- Physiological Parameters: Plasma Concentration of Glucose (Glu) [ Time Frame: up to 48h after surgery ]When venous blood are collected, glucose levels are measured immediately by Glucometer.
- Hemodynamic Parameters: Heart Rate. [ Time Frame: up to 48h after surgery ]Continuous monitoring of heart rate to 48 hours after surgery.
- Hemodynamic Parameters: Mean Arterial Pressure(MAP) [ Time Frame: up to 48h after surgery ]Continuous monitoring of mean arterial pressure(MAP) to 48 hours after surgery. mean arterial pressure(MAP)= (systolic blood pressure+2×diastolic blood pressure)/3
- Anesthetics Consumption: Sufentanil Consumption [ Time Frame: during operation ]Intraoperative superaddition of sufentanil was measured.
- Questionnaire: Pain Scores at Rest [ Time Frame: 1hr, 6hr, 12hr, 24hr, and 48hr after surgery ]Pain scores of the participants will be measured by the Visual Analogue Scale. Measurement of VAS: Draw a 10cm horizontal line on the paper. The VAS were anchored at 0cm(no pain) and 10cm(worst possible pain), the middle part shows varying degrees of pain, the greater of the number, the worse of the pain.
- Questionnaire: Pain Scores on Movement [ Time Frame: 1hr, 6hr, 12hr, 24hr, and 48hr after surgery ]Pain scores of the participants will be measured by the Visual Analogue Scale. Measurement of VAS: Draw a 10cm horizontal line on the paper. The VAS were anchored at 0cm(no pain) and 10cm(worst possible pain), the middle part shows varying degrees of pain, the greater of the number, the worse of the pain.
- Anesthesia Recovery: the Time of First Flatus [ Time Frame: Through study completion, an average of 2 weeks ]The time of first flatus was measured after surgery.
- Anesthesia Recovery: Number of Participants With Prolonged Hospitalization [ Time Frame: Through study completion, an average of 2 weeks ]The percentage of long hospitalization were measured. More than 7 days after surgery is defined as prolonged hospitalization.
- Side Effects: Number of Participants With Sedation [ Time Frame: up to 48h after surgery ]The state of sedation was evaluated after surgery during first postoperative 48 hours.
- Side Effects: Number of Participants With Nausea [ Time Frame: up to 48h after surgery ]The state of nausea was evaluated after surgery during first postoperative 48 hours.
- Side Effects: Number of Participants With Vomiting [ Time Frame: up to 48h after surgery ]The state of vomiting was evaluated after surgery during first postoperative 48 hours.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Consent
- ASA 1-3
- No contraindication to epidural or ropivacaine
- First time surgery for current conditions
- Not on chronic pain medications or sedative
Exclusion Criteria:
- The subject has a known or suspected allergy to opioid analgesics or ropivacaine
- Emergency patients
- The subject has know central nervous system disease or neurological impairment
- The subject has preoperative infection, and a history of immune and endocrine system disease, chemotherapy, or blood transfusion.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03035916
| China, Jilin | |
| China-Japan Union Hospital of Jilin University | |
| Changchun, Jilin, China, 130000 | |
| Principal Investigator: | Guoqing Zhao, doctor | Jilin University |
Documents provided by Zhao Guoqing, Jilin University:
| Responsible Party: | Zhao Guoqing, Clinical Professor, Jilin University |
| ClinicalTrials.gov Identifier: | NCT03035916 |
| Other Study ID Numbers: |
3D5l4L463430 3R210Z893430 ( Other Grant/Funding Number: Jilin Provincial Department of Science and Technology ) |
| First Posted: | January 30, 2017 Key Record Dates |
| Results First Posted: | December 15, 2017 |
| Last Update Posted: | January 23, 2018 |
| Last Verified: | December 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
transversus abdominal plane block epidural anesthesia stress response anesthetic recovery |
|
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs |

